Versant Venture Management, LLC
SAN FRANCISCO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$109.1M2026 Q3
Positions8
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
Versant Venture Management, LLC reported 8 positions worth $109.1M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: GLUE (34.8%). Biggest move: add CTNM ($10.1M).
8 positions shown
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | GLUE | $37.9M | 34.78% | 3,180,780 | — | — | -23.2% | |
| ▸ 2 | IPSC | $20.8M | 19.07% | 12,166,109 | — | — | -4.1% | |
| ▸ 3 | CTNM | $17.3M | 15.90% | 1,292,628 | — | — | -26.5% | |
| ▸ 4 | JBIO | $13.9M | 12.77% | 991,783 | — | — | — | |
| ▸ 5 | LENZ | $10.2M | 9.35% | 2,656,888 | — | — | +7.6% | |
| ▸ 6 | CRSP | $8.2M | 7.55% | 148,831 | — | — | -27.0% | |
| ▸ 7 | SKYE | $404.0K | 0.37% | 250,962 | — | — | -32.3% | |
| ▸ 8 | Tempest Thera… | $225.1K | 0.21% | 269,772 | — | — | — |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Versant Venture Management, LLC hold as of Q3 2026?
Versant Venture Management, LLC reported 8 positions worth $109.1M in its Q3 2026 13F filing. Largest positions: GLUE (34.8%), IPSC (19.1%), CTNM (15.9%), JBIO (12.8%) and LENZ (9.4%).
What did Versant Venture Management, LLC buy in Q3 2026?
New positions: SKYE. Added to: CTNM.
What did Versant Venture Management, LLC sell in Q3 2026?
Sold out entirely: Skye Bioscience, Inc..
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.